Emily Gallagher
- Democratic
- Assembly Member
- District 50
Primary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
No votes to display
AMEND AND RECOMMIT TO CONSUMER AFFAIRS AND PROTECTION
PRINT NUMBER 2289A
REFERRED TO CONSUMER AFFAIRS AND PROTECTION
| Bill Text Versions | Format |
|---|---|
| A2289 | PDF HTML |
| A2289A |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.